Showing 1 - 8 results of 8 for search 'Marc Hoffmann', query time: 0.05s Refine Results
  1. 1
    Apoptotic colopathy following bendamustine therapy

    Apoptotic colopathy following bendamustine therapy by Vincent Czerwinski, Wei Cui, Marc Hoffmann

    Published 2023-11-01
    Get full text
    Article
  2. 2
    The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance

    The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance by Jean-Marc Hoffmann, Annina Bauer, Regina Grossmann

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Academic clinical trials: Publication of study results on an international registry—We can do better!

    Academic clinical trials: Publication of study results on an international registry—We can do better! by Jean-Marc Hoffmann, Regina Grossmann, Annette Widmann

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Anatomical, phenological and genetic aspects of the host–parasite relationship between Andrena vaga (Hymenoptera) and Stylops ater (Strepsiptera)

    Anatomical, phenological and genetic aspects of the host–parasite relationship between Andrena vaga (Hymenoptera) and Stylops ater (Strepsiptera) by Marc Hoffmann, Hanna Gardein, Henri Greil, Silvio Erler

    Published 2023-07-01
    Get full text
    Article
  5. 5
    Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey

    Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey by Jean-Marc Hoffmann, Anette Blümle, Regina Grossmann, Henry Yau, Britta Lang, Cedric Bradbury

    Published 2023-10-01
    Get full text
    Article
  6. 6
    A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma

    A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma by Roman Ludwig, Jean-Marc Hoffmann, Bertrand Pouymayou, Grégoire Morand, Martina Broglie Däppen, Matthias Guckenberger, Vincent Grégoire, Panagiotis Balermpas, Jan Unkelbach

    Published 2022-08-01
    Get full text
    Article
  7. 7
    P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

    P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES by Michal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, Lindsey Roeker, Benoit Tessoulin, Alexey Danilov, Alvaro J. Alencar, Nirav N. Shah, Herve Ghesquieres, Steven Le Gouill, Wojciech Jurczak, Anthony R. Mato, Vishalkumar Patel, Yingying Guo-Avrutin, James M. Pauff, Maciej Kazmierczak

    Published 2023-08-01
    Get full text
    Article
  8. 8
    Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

    Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients by Jean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, Angela Hückelhoven, Leopold Sellner, Leopold Sellner, Sophia Stock, Anita Schmitt, Christian Kleist, Ulrike Gern, Angelica Loskog, Patrick Wuchter, Patrick Wuchter, Susanne Hofmann, Anthony D. Ho, Anthony D. Ho, Carsten Müller-Tidow, Carsten Müller-Tidow, Peter Dreger, Peter Dreger, Michael Schmitt, Michael Schmitt

    Published 2018-01-01
    Get full text
    Article

Search Tools: